All lobbying filings
AGIOS PHARMACEUTICALS
AGIOS PHARMACEUTICALS filed a Q2 amendment for AGIOS PHARMACEUTICALS on July 22, 2025.
Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues
Filing · LD-2 quarterly report
Q2 amendment
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 22, 2025
Expenses
$20,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
3
Sickle Cell policy Biotech innovation
Medicaid reform
Biotech innovation